Renaissance Technologies’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.44M | Sell |
129,117
-26,683
| -17% | -$297K | ﹤0.01% | 2310 |
|
|
2025
Q1 | $1.91M | Buy |
155,800
+69,500
| +81% | +$854K | ﹤0.01% | 2025 |
|
|
2024
Q4 | $966K | Sell |
86,300
-700
| -0.8% | -$7.83K | ﹤0.01% | 2519 |
|
|
2024
Q3 | $606K | Buy |
87,000
+5,800
| +7% | +$40.4K | ﹤0.01% | 2696 |
|
|
2024
Q2 | $614K | Sell |
81,200
-38,771
| -32% | -$293K | ﹤0.01% | 2601 |
|
|
2024
Q1 | $1.58M | Buy |
119,971
+11,646
| +11% | +$154K | ﹤0.01% | 2179 |
|
|
2023
Q4 | $1.12M | Buy |
108,325
+64,040
| +145% | +$660K | ﹤0.01% | 2335 |
|
|
2023
Q3 | $431K | Buy |
44,285
+26,985
| +156% | +$263K | ﹤0.01% | 2778 |
|
|
2023
Q2 | $78K | Buy |
17,300
+2,800
| +19% | +$12.6K | ﹤0.01% | 3523 |
|
|
2023
Q1 | $67K | Buy |
14,500
+1,100
| +8% | +$5.08K | ﹤0.01% | 3592 |
|
|
2022
Q4 | $20K | Buy |
13,400
+200
| +2% | +$299 | ﹤0.01% | 3966 |
|
|
2022
Q3 | $50K | Buy |
13,200
+500
| +4% | +$1.89K | ﹤0.01% | 3759 |
|
|
2022
Q2 | $63K | Buy |
+12,700
| New | +$63K | ﹤0.01% | 3957 |
|